253 related articles for article (PubMed ID: 36939377)
1. NAT10 Drives Cisplatin Chemoresistance by Enhancing ac4C-Associated DNA Repair in Bladder Cancer.
Xie R; Cheng L; Huang M; Huang L; Chen Z; Zhang Q; Li H; Lu J; Wang H; Zhou Q; Huang J; Chen X; Lin T
Cancer Res; 2023 May; 83(10):1666-1683. PubMed ID: 36939377
[TBL] [Abstract][Full Text] [Related]
2. NAT10-mediated mRNA N4-acetylcytidine modification promotes bladder cancer progression.
Wang G; Zhang M; Zhang Y; Xie Y; Zou J; Zhong J; Zheng Z; Zhou X; Zheng Y; Chen B; Liu C
Clin Transl Med; 2022 May; 12(5):e738. PubMed ID: 35522942
[TBL] [Abstract][Full Text] [Related]
3. N-acetyltransferase 10 regulates alphavirus replication via N4-acetylcytidine (ac4C) modification of the lymphocyte antigen six family member E (LY6E) mRNA.
Dang Y; Li J; Li Y; Wang Y; Zhao Y; Zhao N; Li W; Zhang H; Ye C; Ma H; Zhang L; Liu H; Dong Y; Yao M; Lei Y; Xu Z; Zhang F; Ye W
J Virol; 2024 Jan; 98(1):e0135023. PubMed ID: 38169284
[TBL] [Abstract][Full Text] [Related]
4. Helicobacter pylori-induced NAT10 stabilizes MDM2 mRNA via RNA acetylation to facilitate gastric cancer progression.
Deng M; Zhang L; Zheng W; Chen J; Du N; Li M; Chen W; Huang Y; Zeng N; Song Y; Chen Y
J Exp Clin Cancer Res; 2023 Jan; 42(1):9. PubMed ID: 36609449
[TBL] [Abstract][Full Text] [Related]
5. NAT10-mediated mRNA N4-acetylcytidine modification of MDR1 and BCRP promotes breast cancer progression.
Zhao CC; Sun X; Chen J; Geng BD
Thorac Cancer; 2024 Apr; 15(10):820-829. PubMed ID: 38409918
[TBL] [Abstract][Full Text] [Related]
6. N4-acetylcytidine-dependent GLMP mRNA stabilization by NAT10 promotes head and neck squamous cell carcinoma metastasis and remodels tumor microenvironment through MAPK/ERK signaling pathway.
Liu Y; Wang X; Liu Y; Yang J; Mao W; Feng C; Wu X; Chen X; Chen L; Dong P
Cell Death Dis; 2023 Nov; 14(11):712. PubMed ID: 37914704
[TBL] [Abstract][Full Text] [Related]
7. NAT10 Is Involved in Cardiac Remodeling Through ac4C-Mediated Transcriptomic Regulation.
Shi J; Yang C; Zhang J; Zhao K; Li P; Kong C; Wu X; Sun H; Zheng R; Sun W; Chen L; Kong X
Circ Res; 2023 Dec; 133(12):989-1002. PubMed ID: 37955115
[TBL] [Abstract][Full Text] [Related]
8. NAT10-mediated RNA acetylation enhances HNRNPUL1 mRNA stability to contribute cervical cancer progression.
Long Y; Ren Y; Wei Q; Mobet Y; Liu Y; Zhao H; Liu T; Cheng L; Yi P
Int J Med Sci; 2023; 20(8):1079-1090. PubMed ID: 37484809
[TBL] [Abstract][Full Text] [Related]
9. NAT10 regulates the repair of UVB-induced DNA damage and tumorigenicity.
Yang Z; Wilkinson E; Cui YH; Li H; He YY
Toxicol Appl Pharmacol; 2023 Oct; 477():116688. PubMed ID: 37716414
[TBL] [Abstract][Full Text] [Related]
10. The Cytidine N-Acetyltransferase NAT10 Participates in Peripheral Nerve Injury-Induced Neuropathic Pain by Stabilizing SYT9 Expression in Primary Sensory Neurons.
Zhang M; Yang K; Wang QH; Xie L; Liu Q; Wei R; Tao Y; Zheng HL; Lin N; Xu H; Yang L; Wang H; Zhang T; Xue Z; Cao JL; Pan Z
J Neurosci; 2023 Apr; 43(17):3009-3027. PubMed ID: 36898834
[TBL] [Abstract][Full Text] [Related]
11. N-acetyltransferase 10 promotes colon cancer progression by inhibiting ferroptosis through N4-acetylation and stabilization of ferroptosis suppressor protein 1 (FSP1) mRNA.
Zheng X; Wang Q; Zhou Y; Zhang D; Geng Y; Hu W; Wu C; Shi Y; Jiang J
Cancer Commun (Lond); 2022 Dec; 42(12):1347-1366. PubMed ID: 36209353
[TBL] [Abstract][Full Text] [Related]
12. NAT10-mediated ac4C tRNA modification promotes EGFR mRNA translation and gefitinib resistance in cancer.
Wei W; Zhang S; Han H; Wang X; Zheng S; Wang Z; Yang C; Wang L; Ma J; Guo S; Wang J; Liu L; Choe J; Lin S
Cell Rep; 2023 Jul; 42(7):112810. PubMed ID: 37463108
[TBL] [Abstract][Full Text] [Related]
13. CLIC3 interacts with NAT10 to inhibit N4-acetylcytidine modification of p21 mRNA and promote bladder cancer progression.
Shuai Y; Zhang H; Liu C; Wang J; Jiang Y; Sun J; Gao X; Bo X; Xiao X; Liao X; Huang C; Chen H; Jiang G
Cell Death Dis; 2024 Jan; 15(1):9. PubMed ID: 38182571
[TBL] [Abstract][Full Text] [Related]
14. NAT10-mediated N4-acetylcytidine mRNA modification regulates self-renewal in human embryonic stem cells.
Liu R; Wubulikasimu Z; Cai R; Meng F; Cui Q; Zhou Y; Li Y
Nucleic Acids Res; 2023 Sep; 51(16):8514-8531. PubMed ID: 37497776
[TBL] [Abstract][Full Text] [Related]
15. NAT10/ac4C/FOXP1 Promotes Malignant Progression and Facilitates Immunosuppression by Reprogramming Glycolytic Metabolism in Cervical Cancer.
Chen X; Hao Y; Liu Y; Zhong S; You Y; Ao K; Chong T; Luo X; Yin M; Ye M; He H; Lu A; Chen J; Li X; Zhang J; Guo X
Adv Sci (Weinh); 2023 Nov; 10(32):e2302705. PubMed ID: 37818745
[TBL] [Abstract][Full Text] [Related]
16. NAT10 promotes the tumorigenesis and progression of laryngeal squamous cell carcinoma through ac4C modification of FOXM1 mRNA.
Li Z; Li D; Yang T; Yao C
Cancer Biol Ther; 2023 Dec; 24(1):2274143. PubMed ID: 37948132
[TBL] [Abstract][Full Text] [Related]
17. Acetyltransferase NAT10 regulates the Wnt/β-catenin signaling pathway to promote colorectal cancer progression via ac
Jin C; Wang T; Zhang D; Yang P; Zhang C; Peng W; Jin K; Wang L; Zhou J; Peng C; Tan Y; Ji J; Chen Z; Sun Q; Yang S; Tang J; Feng Y; Sun Y
J Exp Clin Cancer Res; 2022 Dec; 41(1):345. PubMed ID: 36522719
[TBL] [Abstract][Full Text] [Related]
18. The LINC00623/NAT10 signaling axis promotes pancreatic cancer progression by remodeling ac4C modification of mRNA.
Feng Z; Li K; Qin K; Liang J; Shi M; Ma Y; Zhao S; Liang H; Han D; Shen B; Peng C; Chen H; Jiang L
J Hematol Oncol; 2022 Aug; 15(1):112. PubMed ID: 35978332
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles of RNA ac4C modification and NAT10 in mammalian development and human diseases.
Zhang Y; Lei Y; Dong Y; Chen S; Sun S; Zhou F; Zhao Z; Chen B; Wei L; Chen J; Meng Z
Pharmacol Ther; 2024 Jan; 253():108576. PubMed ID: 38065232
[TBL] [Abstract][Full Text] [Related]
20. N4-Acetylcytidine Drives Glycolysis Addiction in Gastric Cancer via NAT10/SEPT9/HIF-1α Positive Feedback Loop.
Yang Q; Lei X; He J; Peng Y; Zhang Y; Ling R; Wu C; Zhang G; Zheng B; Chen X; Zou B; Fu Z; Zhao L; Liu H; Hu Y; Yu J; Li F; Ye G; Li G
Adv Sci (Weinh); 2023 Aug; 10(23):e2300898. PubMed ID: 37328448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
